Dobutamine cine magnetic resonance imaging after myocardial infarction;Cine risonanza magnetica con dobutamina dopo infarto del miocardio

Radiologia Medica

Volumn 98, Issue 6, 1999, Pages 482-489

  Giovagnoni, Andrea ^a,b   Ligabue, Guido ^a   Rossi, Rosario ^a   Muia, Nicola ^a   Modena, Maria Grazia ^a   Romagnoli, Renato ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Oncologiche R   (Italy)

Author keywords

Dobutamine Cine MRI; Infarction; Myocardial infarction; Myocardium; Stress echocardiography

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CINERADIOGRAPHY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVASCULARIZATION; STRESS ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIOTONIC AGENTS; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TIME FACTORS;

EID: 0033492832     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Afridi I, Kleiman NS, Raizner AE e Coll: Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91: 663-670, 1995.
2. Afridi I, Main ML, Grayburn PA: Accuracy of dobutamine echocardiography for detection of myocardial viability in patients with an occluded left anterior descending coronary artery. J Am Coll Cardiol 28: 455-459, 1996.
3. American Society of Echocardiography Committee Standards, Subcommittee on quantification of two-dimensional echocardiograms: recommendation for quantification of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr 5: 358-367, 1989.
4. Baer FM, Thiessen P, Shneider CA e Coll: Dobutamine Magnetic Resonance Imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31: 1140-1148, 1998.
5. Baer FM, Voth E, Theissen P e Coll: Gradient echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenosis. Eur Heart J 15: 218-225, 1994.
6. Balzer P, Furber A, Le Jeune JJ: Simultaneous and correlated detection of endocardial and epicardial borders on short-axis MR Images for the measurements of left ventricular mass. RadioGraphics. 18: 1009-1018, 1998.
7. Bonow RO, Ditsizan V, Cuocolo A e Coll: Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular infarction. Circulation 83: 26-37, 1991.
8. Buller VGM, Van der geest RJ, Kool MD e Coll: Accurate three-dimensional wall thickness measurement from multislice short-axis MR Imaging. Comp Cardiol 245-248, 1995.
9. Cigarroa CG, De Filippi CR, Brickner ME e Coll: Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88: 430-436, 1993.
10. Dendale P, Franken PR, Holman E e Coll: Validation of low-dose dobutamine Magnetic Resonance Imaging for assessment of myocardial viability after infarction by serial imaging. Am J Cardiol 82: 375-377, 1998.
11. Dendale PAC, Franken PR, Waldman GJ e Coll: Low-dosage dobutamine Magnetic Resonance Imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am Heart J 130: 134-140, 1995.
12. Dislizian V, Rocco TP, Freedman NMT e Coll: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Eng J Med 323: 141-146, 1990.
13. Germain P, Roul G, Constantinesco A e Coll: Comparison between abnormalities in segmental endocardial motion and abnormalities in wall thickening after anterior myocardial infarction. Europ Heart J 17: 1350-1361, 1996.
14. Geskin G, Kramer CM, Rogers WJ e Coll: Quantitative assessment of myocardial viability after infarction by dobutamine Magnetic Resonance tagging. Circulation 98: 217-223, 1998.
15. Gropler RJ, Bergman SR: Myocardial viability - What is the definition? J Nud Med 32: 10-12, 1991.
16. Herman MV, Gorlin R: Implication of left ventricular asynergy. Am J Cardiol 23: 538-547, 1969.
17. Higgins CB, Lund GK, Sakuma H: Coronary flow reserve: assessment by Magnetic Resonance Imagine. Rays 24: 119-130, 1999.
18. Holman ER, Buller VGM, De Roos A e Coll: Detection and quantification of dysfunctional myocardium by Magnetic Resonance Imaging: a new three-dimensional method for quantitative wall-thickening analysis. Circulation 95: 924-931, 1997.
19. Johnston DL, Gupta VK, Wendt RE e Coll: Detection of viable myocardium in segments with fixed defects on thallium-201 scintigraphy: usefulness of Magnetic Resonance Imaging early after acute myocardial infarction. J Magn Reson Imag 11: 949-956, 1993.
20. Lee K, Marwick TH, Cook SA e Coll: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 90: 2687-2694, 1994.
21. Lidner JR, Kaul S: Assessment of myocardial viability with two dimensional echocardiography and magnetic resonance imaging. J Nucl Cardiol 3: 167-182, 1996.
22. Linares OA, Smith MJ, Starling MR e Coll: Dobutamine pharmacokinetics during dobutamine stress echocardiography. Am J Cardiol 79: 1381-1386, 1997.
23. Lotan CS, Cranney GB, Bouchard A e Coll: The value of cine nuclear Magnetic Resonance Imaging for assessing regional left ventricular function. J Am Coll Cardiology 14: 1721-1729, 1989.
24. Meese RB, Spritzer CE, Negro-Vilar R e Coll: Detection, characterization and functional assessment of reperfused Q-wave acute myocardial infarction by cine Magnetic Resonance Imaging. Am J Cardiol 66: 1-9, 1990.
25. Oh JK, Seward JB, Tajik AJ: Manuale di Ecocardiografia (The Echo manual by the Mayo Foundation). Il Pensiero Scientifico Editore, cap 6: 70, 1993.
26. Peshock RM, Rokey R, Malloy CM e Coll: Assessment of myocardial systolic wall thickening using nuclear Magnetic Resonance Imaging. J Am Coll Cardiology 14: 653-659, 1989.
27. Pennel DJ, Firmin DN, Burger P: Assessment of Magnetic Resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery disease. Br Heart J 74: 163-170, 1995.
28. Pennel DJ, Underwood SR, Manzara CC: Magnetic Resonance Imaging during dobutamine stress in coronary artery disease. Am J Cardiol 70: 34-40, 1992.
29. Pierard LA, De Landsheere CM, Berthe C e Coll: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolic therapy: comparison with positron emission tomography. J Am Coll Cardiol 15: 1021-1031, 1990.
30. Ragosta M, Beller GA, Watson DD e Coll: Quantitative planar rest-redistribution 201TI imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severly depressed left ventricular function. Circulation 87: 1630-1641, 1993.
31. Santoro GM, Bisi G, Sciagrà R e Coll: Single photon emission computed tomography with technetium-99m hexasis 2-methoxyisobutil isonitrile in acute myocardial infarction and prediction of late functional recovery. J Am Coll Cardiol 15: 301-314, 1990.
32. Sayad DE, DuWayne LW, Hundley WG e Coll: Dobutamine Magnetic Resonance Imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization. Am J Cardiol 82: 1149-1151, 1998.
33. Sayad DE, DuWaine L, Willet L e Coll: Noninvasive quantification of left ventricular wall thickening using cine Magnetic Resonance Imaging with myocardial tagging. Am J Cardiol 76: 985-989, 1995.
34. Severi S, Underwood R, Mohiaddin RH e Coll: Dobutamine stress effects on regional myocardial blood flow and wall motion. J Am Coll Cardiol 26: 1187-1195, 1995.
35. Sklenar J, Ismail S, Villaneuva FS e Coll: Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion. Circulation 90: 1502-1512, 1994.
36. Smart SC, Sawada S, Ryan T e Coll: Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolic therapy of acute myocardial infarction. Circulation 88: 405.415, 1993.
37. Van Rugge FP, Van der Wall EE, Spanjersberg SJ: Magnetic Resonance Imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 90: 127-138, 1994.
38. Villa A, Meloni G, Montagna C e Coll: Magnetic Resonance Imaging in the study of ischemic hear: disease. Rays 24: 33-45, 1999.
39. Warlter DC, Zyvolosky M, Gross GJ e Coll: Redistribution of myocardial blood flow distal to a dynamic coronary arterial stenosis by a sympathomimetic amines: comparison of dopamine, dobutamine and isoprotenerol. Am J Cardiol 48: 269-279, 1981.
40. Watada H, Ito H, Oh H e Coll: Dobutamine stress echocardiography predicts reversible J dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 24: 624-630, 1994.